CausalSentinel

Protein Dossier — PLAT (Tissue-type plasminogen activator)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Diagnoses - main ICD10: N81 Female genital prolapse 0.265 0.0923 0.00412 Wald ratio 1 cis NA
Caudate volume -83.5 33.2 0.0117 Wald ratio 1 cis NA
Low grade serous ovarian cancer 0.808 0.329 0.014 Wald ratio 1 cis NA
Diagnoses - main ICD10: M54 Dorsalgia 0.212 0.0904 0.0188 Wald ratio 1 cis NA
Rheumatoid arthritis -0.286 0.123 0.0204 Wald ratio 1 cis NA
Weight -0.0286 0.0126 0.023 Wald ratio 1 cis NA
Fractured bone site(s): Ankle 0.224 0.0985 0.0232 Wald ratio 1 cis NA
Putamen volume -88.2 40.9 0.0309 Wald ratio 1 cis NA
Diagnoses - main ICD10: D12 Benign neoplasm of colon rectum anus and anal canal 0.202 0.0996 0.0423 Wald ratio 1 cis NA
Diagnoses - main ICD10: G47 Sleep disorders 0.285 0.143 0.0464 Wald ratio 1 cis NA
Thalamus volume -82.5 42.2 0.0508 Wald ratio 1 cis NA
Melanoma -0.674 0.348 0.0526 Wald ratio 1 cis NA
…and 86 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-2212_69_1 tPA Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

9 association rows across 8 traits (7 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Circulating PLAT levels 1e-52 rs8178885 1 GCST90859980 no MR -> candidate analysis
PLAT protein levels 2e-51 rs2020921 1 GCST90470250 no MR -> candidate analysis
Tissue-type plasminogen activator levels 3e-43 rs8178885 2 GCST90249945 no MR -> candidate analysis
Height 1e-26 rs2020922 1 GCST90245848 MR: beta=-0.0291, p=0.0568 (cis)
Plasma plasminogen activator levels 2e-8 rs2020921 1 GCST002374 no MR -> candidate analysis
Systemic lupus erythematosus 3e-8 rs1804182 1 GCST005752 no MR -> candidate analysis
Hair color 9e-8 rs2070711 1 GCST007082 no MR -> candidate analysis
Carboxyethyl-GABA levels in elite athletes 7e-6 rs3020640 1 GCST90133545 no MR -> candidate analysis

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 1921 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
pulmonary embolism 0.195 established (curated) MR: beta=-0.446, p=0.0977 (cis)
placental abruption 0.564 common-variant locus no MR -> candidate analysis
preeclampsia 0.468 common-variant locus no MR -> candidate analysis
memory impairment 0.466 common-variant locus no MR -> candidate analysis

Of the 4 rows above, 3 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 8 known modulators (Tissue-type plasminogen activator)
gnomAD constraint pLI=2.3e-10, LOEUF=0.816 — LoF-tolerant
GWAS Catalog 19 unique SNPs / 38 rows
ClinVar 178 records; 3 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance